Find Academic Supervisors

Camila AquinoView profile

Assistant Professor

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +5 more

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

• Computer Vision
• Artificial Intelligence
• Machine Learning
• +4 more

Andrew Zisserman is a Royal Society Research Professor at the University of Oxford's Department of Engineering Science, affiliated with the Visual Geometry Group (VGG). His research focuses on computer vision, artificial intelligence, and neural networks, with significant contributions to multimodal learning, video understanding, and 3D scene analysis. He leads projects exploring visual-language models, audio-visual synchronization, and clinical imaging applications. Key research areas include: Video analysis and temporal modeling Multimodal systems for sign language translation and action recognition 3D shape estimation and physical property inference Foundation models and cross-modal retrieval Recent work highlights: Developed Flamingo and Tapir models for video-language tasks Advancements in spinal MRI analysis and clinical imaging Leadership in EGO4D and VoxCeleb challenges Honors include Fellowship of the Royal Society (FRS) and the ISSLS Prize in Clinical Science 2023 for spinal analysis innovations. His lab collaborates globally, emphasizing real-world applications in healthcare and autonomous systems.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +7 more

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

• Neuroimaging
• Neurodegenerative Diseases
• Alzheimer's Disease
• +4 more

Federica Agosta is an Associate Professor of Neurology at Vita-Salute San Raffaele University (UniSR) and Functional Unit Head at San Raffaele Hospital (OSR) , Milan, Italy. Her research focuses on neuroimaging in neurodegenerative diseases , including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS). PhD in Experimental Neurology (2012), UniSR Neurology Qualification (2008), UniSR MD in Medicine and Surgery (2003), UniSR Research Interests : Federica Agosta's work bridges functional MRI (fMRI) with clinical applications in neurodegenerative disorders. She investigates: Brain network alterations in Alzheimer's and Parkinson's Neuroimaging biomarkers for ALS and dementia Gender-specific neurological manifestations Advanced MRI techniques for early disease detection Cognitive rehabilitation strategies Neurodegeneration and brain connectivity Recent Publications highlight trends in neuroimaging endpoints for ALS, memory systems, Parkinson's scales, sleep apnea, and epilepsy diagnostics. Her ERC Starting Grant (2017) and European Grand Prix for Young Researcher (2019) underscore her leadership in neurodegenerative disease research. Scientific Roles : Coordinator, Doctoral Program in Cognitive and Behavioral Sciences (UniSR, 2024–) Co-PI, San Raffaele Neurotech Hub (2024–) President, Master's Degree Council in Rehabilitation Sciences (2021–) Visiting Professor, University of Belgrade (2017–) Editorial & Societal Contributions : Member of the EAN Scientific Committee , Co-Chair of the ALS & FTD Panel , and active roles in societies like SIN and SINdem . She serves on editorial boards for Neurological Sciences and Neurology .

• Inverse Problems
• Nonlinear Acoustics
• Medical Imaging
• +5 more

Yang Zhang is a Visiting Assistant Professor in the Department of Mathematics at the University of California, Irvine (UCI), working under Prof. Katya Krupchyk. His research focuses on inverse problems in imaging sciences, nonlinear hyperbolic equations, and medical imaging applications. He previously held a postdoctoral position at the University of Washington, Seattle, under Prof. Gunther Uhlmann. His work integrates microlocal analysis and partial differential equations to address challenges in wave propagation, nonlinear acoustics, and elasticity. Education & Career: PhD from Purdue University (advisor: Prof. Plamen Stefanov) Postdoc: University of Washington, Seattle (2020–2024) Research Interests: Dr. Zhang's work spans inverse problems for nonlinear hyperbolic equations, acoustic imaging, and integral transforms in medical contexts. He develops novel methodologies using multi-fold linearization, wave interactions, and advanced calculus techniques. His studies on Rayleigh and Stoneley waves in elasticity further demonstrate his expertise in microlocal analysis. Key Contributions: His research bridges theoretical mathematics and applied imaging, with notable publications on inverse scattering, damping effects in wave equations, and Compton camera imaging. He is an active member of the Inverse Problems International Association (IPIA). Grants & Collaborations: Collaborations with prominent figures like Prof. Gunther Uhlmann and Prof. Katya Krupchyk highlight his network in inverse problems. His work often involves both analytical and computational approaches, with applications in medical diagnostics and geophysics.

Dietmar DammererView profile

Associate Clinical Professor

• Orthopedic Surgery
• Traumatology
• Endoprosthetics
• +7 more

Prim. Clin. Assoc. Prof. PD Dr. Dietmar Dammerer, MSc PhD is the head of the Clinical Department of Orthopaedics and Traumatology at Krems University Hospital, affiliated with Karl Landsteiner Private University of Health Sciences. He has been in this role since February 2022, leading the merger of orthopedics and traumatology into a unified clinical department. A dual-trained specialist, he is recognized for his expertise in endoprosthetics and tumor orthopedics, and actively promotes interdisciplinary collaboration and team-based medicine. His educational background includes a PhD in Musculoskeletal Sciences (2015), an MSc in Advanced Orthopaedics and Traumatology (2017), and board certification in both orthopedics and traumatology (2017, 2018), culminating in habilitation in 2019. He has received prestigious Traveling Fellowships from the European Hip Society and European Musculo-Skeletal Oncology Society. Dietmar Dammerer’s research focuses on orthopedic oncology, joint reconstruction, biomechanics, and minimally invasive surgery. His work emphasizes the integration of clinical inquiry with research to improve patient outcomes. Recent publications analyze pelvic sarcoma reconstruction, spinal metastases, cartilage repair techniques, and health disparities in sarcoma care. His 15 most recent articles reflect a strong trend in musculoskeletal oncology, surgical biomechanics, and evidence-based orthopedic practice, with frequent use of systematic reviews, retrospective studies, and multicenter collaborations. Topics include implant performance, surgical safety, and global access to specialized care. Scientific awards include: Traveling Fellow Stipendium from the European Hip Society (2018) Traveling Fellow Stipendium from the European Musculo-Skeletal Oncology Society (2020) He is deeply committed to mentoring and team development, emphasizing that medical success is measured by the success of one’s colleagues. He leads a research-active department that hosts international observers, conducts training courses for physicians across Europe, the Middle East, and Africa, and maintains a high rate of peer-reviewed publication. The department collaborates closely with the Departments of Biomechanics and Anatomy and Developmental Biology, reflecting a multidisciplinary research approach.

• Neurology
• Neuromuscular Diseases
• Inherited Neuropathies
• +6 more

Professor Mary M. Reilly is a distinguished academic and clinician serving as Professor of Neurology in the Department of Neuromuscular Diseases at University College London's Queen Square Institute of Neurology. She is also a consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. Her academic appointments include: Professor of Neurology, University College London, Department of Neuromuscular Diseases Head of the Division of Clinical Neurology, UCL Queen Square Institute of Neurology Lead of the peripheral nerve clinical and research group Professor Reilly's research focuses on inherited neuropathies, with particular emphasis on Charcot-Marie-Tooth disease (CMT) and hereditary transthyretin amyloidosis (hTTRA). Her work spans the entire translational pipeline, from gene identification and pathogenetic studies through natural history studies and outcome measure development to clinical trials. She approaches her research with a patient-centered perspective, with questions arising directly from clinical encounters. Her extensive publication record demonstrates consistent contributions to understanding various forms of Charcot-Marie-Tooth disease, amyloid neuropathies, and other inherited peripheral nerve disorders. Her research employs diverse methodologies including genomic analysis, biomarker development, imaging techniques, and international collaborative studies to advance understanding and treatment of these conditions. Professor Reilly has received significant recognition for her work: Elected Fellow of the Academy of Medical Sciences (2020) Awarded Fellow of the European Academy of Neurology (2023) Past President of the Association of British Neurologists (ABN) Past President of the British Peripheral Nerve Society (BPNS) Past President of the international Peripheral Nerve Society (PNS) Current chair of the Guarantors of Brain Professor Reilly has made substantial contributions to education and mentorship in the field. As Director of Training in the inherited neuropathy consortium (INC), she developed and runs an international inherited neuropathy fellowship scheme since 2009, with 14 fellows completed. She established and directed an international fellowship program through the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNDM) between 2019-2024, connecting institutions across UK, Brazil, India, South Africa, Zambia and Turkey. She also successfully ran the MRC Neuromuscular PhD programme between 2008 and 2018, mentoring 39 students. She leads the MRC Centre for Neuromuscular Diseases Biobank London, which plays a crucial role in advancing research on rare and neuromuscular diseases through the collection and analysis of biological samples.

Ajaz SheikhView profile

Associate Professor

• Sleep Medicine
• Intraoperative Monitoring
• Epilepsy
• +3 more

Ajaz Sheikh, M.D. serves as Associate Professor and Director of the Clinical Neurophysiology Fellowship Program at the University of Toledo College of Medicine, specializing in Epilepsy, Sleep Medicine, and Intraoperative Monitoring. His clinical work integrates advanced neurophysiological diagnostics with comprehensive patient care at the Neuroscience Center. Education: M.B.B.S: University of Kashmir, Government Medical College Srinagar (1998-2004) Internship: University of Toledo (2010-2011) Residency: Psychiatry (University of Kashmir, 2005-2008); Neurology (University of Toledo, 2011-2014) Fellowship: Clinical Neurophysiology/Epilepsy (Case Medical Center, 2014-2015); Sleep Medicine (Duke University, 2015-2016) Dr. Sheikh's research examines seizure triggers, comorbidities in drug-resistant epilepsy, and neurophysiological diagnostic challenges. His work bridges clinical practice with systematic reviews on rare neurological conditions like CLIPPERS and Isaac Syndrome, emphasizing practical applications for improving diagnostic accuracy and treatment protocols in neurocritical care settings. Recent publications (2023-2025) reveal a strong focus on epilepsy comorbidities, with significant contributions to understanding ADHD-epilepsy interactions, geriatric seizure patterns, and autoimmune neurological disorders. His systematic reviews on CLIPPERS and Isaac Syndrome demonstrate methodological rigor while addressing critical gaps in rare disease management. Scientific Awards: Alpha Omega Alpha Induction (2023) A.B. Baker Teaching Recognition Award (2020) Outstanding Neurology Attending Award (2018-2019) Arnold P. Gold Humanism Award (2013, 2014) Outstanding Resident Teaching Award (2014) As Principal Investigator for the ENGAGE-E-001 alprazolam trial and Co-Investigator on four active epilepsy drug studies (natalizumab, padsevonil, XEN1101, SAGE-547), Dr. Sheikh leads translational research targeting super-refractory status epilepticus and drug-resistant focal epilepsy. His prior work in Kashmir included schizophrenia and depression drug trials, reflecting global research engagement. Through the Clinical Neurophysiology Fellowship Program, Dr. Sheikh trains next-generation neurophysiologists while collaborating on multi-center trials that advance evidence-based protocols for complex seizure disorders and intraoperative monitoring standards.

Eric NaumanView profile

Professor

• Traumatic Brain Injury (TBI)
• Spinal Cord Injury (SCI)
• Musculoskeletal Damage
• +5 more

Eric Nauman is the Dane A. and Mary Louise Miller Professor of Biomedical Engineering at the University of Cincinnati and director of the Human Injury Research and Regenerative Technologies (H.I.R.R.T.) Lab. Previously, he held academic roles at Purdue University and Tulane University. He earned his Ph.D., M.S., and B.S. in Mechanical Engineering from UC Berkeley and the University of Delaware. Research Focus: The H.I.R.R.T. Lab investigates mechanisms of traumatic brain injury, spinal cord injury, musculoskeletal damage, atherosclerosis, and cancer metastasis. It develops protective and reconstructive treatments, including FDA-approved engineered tissue products for tendon repair. Collaborative projects emphasize translational research in injury prevention and treatment delivery. Grants & Awards: Lead Principal Investigator (PI) on federal grants totaling $4.7M for projects like AFRL teeming agreements and DoD biomathematical models. Recipient of prestigious awards including the Purdue Book of Great Teachers, Innovators Hall of Fame, and multiple teaching excellence recognitions. Key Contributions: Co-authored landmark TBI studies, holds 14 U.S. patents, and pioneered protective equipment innovations. His work bridges biomechanics, materials science, and clinical applications.

Cornelius FaberView profile

Professor

• MRI cell tracking
• infection imaging
• MR methodology
• +6 more

Cornelius Faber is a University Professor in the Department of Radiology at the University of Münster, Germany, where he leads the Experimental Nuclear Magnetic Resonance research group. His work focuses on developing and implementing novel MRI techniques that extend the boundaries of magnetic resonance imaging in terms of spatial and temporal resolution, sensitivity, and specificity for physiological, structural, and molecular changes. He actively participates in the "Cells in Motion" interdisciplinary research initiative at the university. Professor Faber's research spans multiple critical areas in medical imaging and biomedical science. His primary expertise lies in MRI cell tracking , enabling visualization of cellular dynamics in vivo. He has made significant contributions to infection imaging , developing methods to detect and characterize microbial infections using MRI. His work on MR methodology development has advanced quantitative imaging techniques, while his research on multimodal integration in MR and MRI contrast mechanisms has provided deeper insights into molecular and cellular processes. His research bridges physics, engineering, and biomedical applications, with particular relevance to inflammation, cancer, neurological disorders, and cardiovascular disease. Analysis of Professor Faber's extensive publication record reveals a clear evolution from fundamental MRI technique development toward increasingly sophisticated applications in disease models. His recent work demonstrates a strong trend toward multimodal imaging approaches that combine MRI with complementary techniques such as mass spectrometry, optical imaging, and PET. This integration creates comprehensive diagnostic platforms that provide both anatomical and molecular information. A notable pattern is the focus on cellular dynamics, particularly immune cell behavior in inflammatory conditions and tumor microenvironments, with applications spanning neuroscience, oncology, and cardiology. Professor Faber leads a multidisciplinary research team of approximately 15 members, including scientists, doctoral students, technicians, and medical students. His laboratory is deeply integrated with the University of Münster's research infrastructure, particularly the Multiscale Imaging Centre. The group's work contributes significantly to advancing preclinical MRI methodologies while maintaining strong clinical relevance, with numerous publications in high-impact journals across medical imaging, neuroscience, and biomedical engineering disciplines.

Sheng SangView profile

Assistant Professor

• Mechanical Engineering
• Biomedical Engineering
• Machine Learning
• +7 more

Sheng Sang is an Assistant Professor in the Department of Engineering Sciences at Bethany Lutheran College. His research lies at the intersection of Mechanical Engineering and Biomedical Engineering, with a strong emphasis on machine learning applications in composite materials and elastic metamaterials. His research interests include: Mechanical & Biomedical Engineering Machine Learning on Composites Elastic Metamaterials and Composites Optimization of Medical Devices Finite Element Modeling and Simulation Dr. Sang's recent publications demonstrate a consistent focus on integrating deep learning techniques with mechanical systems, particularly in predicting composite microstructures, tracking particles in complex systems, and optimizing wave propagation in metamaterials. His work frequently employs 3D CNNs and other neural architectures to solve inverse problems in material science. Scientific awards and recognition include: Dr. Lehtola Fellowship Research Grant ($9,000, PI), 2021–2023 Graco Engineering Lab Development Grant ($60,000), 2020–2022 He has been actively involved in teaching a wide range of engineering courses such as Fluid Mechanics, Solid Mechanics, Thermodynamics, and Computer-Aided Design. His research is supported by external grants, indicating active supervision and project leadership. Dr. Sang has collaborated with researchers across disciplines, including neuroscience and medical imaging, particularly in studies involving deep brain stimulation and fMRI. He is affiliated with research teams working on: Active elastic metamaterials design Machine learning for material characterization Optimization of biomedical devices using swarm intelligence Development of advanced simulation tools for composite systems

Michael C. NevittView profile

Professor

• Osteoarthritis
• Osteoarthritis biomarkers
• Osteoporosis
• +2 more

Dr. Michael C. Nevitt is a Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco. He is a leading expert on the epidemiology of osteoarthritis (OA) of the knee and hip, with a distinguished career focused on understanding the risk factors, progression, and imaging biomarkers of joint diseases. Dr. Nevitt leads the Coordinating Center for two landmark studies of knee OA: the Osteoarthritis Initiative (OAI) and the Multicenter Osteoarthritis (MOST) Study. These are the first large longitudinal cohort studies in the US to focus on OA of the knee using MR imaging. The OAI provides a public use dataset that is widely used by investigators worldwide. He is also the Principal Investigator of the SOF Hip OA study. His research focuses on osteoarthritis epidemiology , with particular emphasis on imaging biomarkers and the relationship between bone mineral density and joint disease progression. His work has significantly advanced our understanding of how changes in bone structure precede the onset of radiographic hip OA and how high bone mineral density affects knee OA development. Analysis of Dr. Nevitt's publications reveals a consistent focus on methodological rigor in OA research, with significant contributions to imaging protocols, diagnostic criteria, and longitudinal study design. His work spans both knee and hip OA, with important connections to osteoporosis research. Imaging innovations - Development of standardized MRI protocols for knee OA assessment Risk factor identification - Establishing relationships between bone geometry and OA onset Diagnostic criteria - Defining incident radiographic hip OA for epidemiological studies As principal investigator of major longitudinal studies, Dr. Nevitt has created valuable resources for the research community while advancing our fundamental understanding of osteoarthritis pathogenesis and progression.

Christopher D. AbrahamView profile

Associate Professor

• Radiation Oncology
• Neuro-Oncology
• Brain Tumor Treatment
• +4 more

Christopher D. Abraham, MD is an Associate Professor of Radiation Oncology and Associate Professor of Medicine at Washington University School of Medicine in St. Louis. He is affiliated with the Siteman Cancer Center, Brain Tumor Center, and Institute of Clinical and Translational Sciences (ICTS). Dr. Abraham practices at multiple locations including the Center for Advanced Medicine Radiation Oncology Center, Barnes-Jewish West County Hospital, and Siteman Cancer Center – North County. His clinical work focuses on radiation oncology with expertise in treating brain tumors and other cancers. Dr. Abraham completed his Medical Degree at Saint Louis University School of Medicine in 2011 and his Residency in Radiation Oncology at Barnes-Jewish Hospital and Washington University School of Medicine in 2016. He earned his BS in Radiologic Science from the Medical College of Georgia in 2004. Dr. Abraham's research focuses on advancing radiation therapy techniques, particularly in stereotactic radiosurgery for brain metastases, hippocampal-avoidance whole brain radiation therapy, and innovative approaches for glioblastoma treatment. His work demonstrates a strong emphasis on optimizing radiation delivery while minimizing neurocognitive side effects. He has pioneered simulation-free radiation therapy techniques that expedite treatment planning, particularly for palliative care patients. His research also explores the integration of AI and large language models in radiation oncology workflows and insurance appeals processes. Analysis of Dr. Abraham's recent publications reveals a clear research trajectory focused on improving precision in radiation therapy for brain tumors, with particular attention to hippocampal protection, adaptive planning techniques, and combined modality approaches. His work spans clinical trials, technical innovations in treatment planning, and translational research connecting imaging with treatment outcomes. The increasing citation counts of his work, particularly his 2023 paper on simulation-free radiation therapy which has 34 citations, demonstrates growing impact in the field. While specific awards are not listed in the provided information, Dr. Abraham's work has accumulated 536 citations according to Scopus metrics, indicating significant scholarly impact. His research has been referenced in clinical guidelines and policy sources, demonstrating translational relevance to clinical practice. Dr. Abraham actively collaborates with multidisciplinary teams including neurosurgeons, medical oncologists, and physicists. His work on the NRG Oncology/RTOG 0631 trial demonstrates involvement in large cooperative group studies. He has contributed to efforts examining insurance policy adherence to radiation oncology guidelines, showing engagement with healthcare systems issues. As a key member of the Brain Tumor Center at Siteman Cancer Center, Dr. Abraham participates in comprehensive brain tumor care teams that integrate surgical, medical, and radiation oncology approaches. His work with the Institute of Clinical and Translational Sciences highlights his commitment to translating research findings into clinical practice. Current research directions include exploring simulation-free radiation therapy techniques, optimizing hippocampal-sparing approaches, and investigating novel combinations of radiation with immunotherapies.

• MR Imaging
• MR Elastography
• Low-field MRI
• +5 more

Dr. Najat Salameh is a Senior Lecturer at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition, where she leads the Medical Imaging Technologies theme at the Institute of Medical Sciences. She co-founded the Center for Adaptable MRI Technology (AMT Center) in 2017 and relocated it to Aberdeen in April 2023, establishing what will become the largest low-field MR technology platform with approximately 900 m 2 of lab and office space at the Foresterhill campus. Her educational background includes: PhD in Biomedical Sciences from Université Catholique de Louvain (2009) DEA (Master) in Health Sciences from Université Catholique de Louvain (2008) Diplôme ès Sciences Physiques from University of Geneva (2005) Dr. Salameh has developed over 20+ years of expertise in MR imaging, positioning herself at the interface between Physics and Medicine. Her research spans from fundamental physics to microsurgery in rodents, with specialization in MR elastography for liver and brain applications, thermometry, metabolic imaging, and low magnetic field MRI systems. She designs, implements, and validates imaging protocols across magnetic fields ranging from 0.0065 T to 9.4 T, with a strong focus on making MRI technology more accessible and adaptable for clinical use. Her work bridges the gap between advanced imaging technology development and practical clinical applications. Her recent publication portfolio reveals a clear trajectory toward practical implementation of low-field MRI systems, with emphasis on hardware innovation, deep learning applications for image reconstruction, and clinical translation of MR elastography techniques. The research demonstrates significant progress in making quantitative tissue characterization more accessible through cost-effective imaging solutions. Her scientific recognition includes: V-LF-Spiro3D grant from Research Councils UK (2023-2027) for low-field 3D magnetic resonance spirometry Interventional and susceptibility artifact-free MR Imaging award from Swiss National Science Foundation (2017-2021) In vivo detection and imaging of free radicals using the Overhauser effect grant from Swiss National Science Foundation (2013-2014) MR elastography for chronic liver diseases award from Fonds pour la formation à la recherche dans l'industrie et l'agriculture (2005-2009) As co-founder and leader of the AMT Center, Dr. Salameh collaborates with Dr. Sarracanie, Dr. Broche, and Dr. Ross on developing the next generation of low-field MRI technology. Her center is currently establishing a major research infrastructure with three fixed low-field scanners and two Field-Cycling whole-body systems in a newly refurbished facility, positioning Aberdeen as a global hub for adaptable MRI technology development. The Center for Adaptable MRI Technology represents a significant investment in accessible imaging technology, with the relocated platform forming what will be the largest low-field MR technology facility globally. This initiative supports research across multiple clinical applications while addressing the need for more affordable and widely deployable imaging solutions.

John CrawfordView profile

Professor

• Neurology
• Pediatrics
• Neuroimaging
• +4 more

John Crawford, MD serves as Division Chief of Neurology within the Department of Pediatrics and holds a Professor appointment in both Pediatrics and Neurology at the University of California, Irvine School of Medicine. His clinical and research activities focus on complex neurological conditions in pediatric patients with particular expertise in neuroimaging applications. Dr. Crawford's research interests span multiple domains of pediatric neurology including neuroimaging , neurooncology , and genetic neurological disorders . His work demonstrates particular focus on MRI characterization of spinal cord tumors and intraventricular lesions in children, as well as neuroimaging features associated with chromosomal abnormalities. His publications reveal strong integration of radiological findings with pathological and genetic data to advance diagnostic approaches in pediatric neurology. Analysis of his recent publications shows consistent focus on Advanced MRI techniques for tumor characterization Correlation between imaging findings and pathological diagnoses Genetic underpinnings of neurological disorders visible on imaging His work bridges clinical neurology, radiology, and molecular pathology to improve diagnostic precision in complex pediatric neurological cases. Dr. Crawford's leadership as Division Chief indicates significant administrative responsibilities alongside his clinical and research activities. His position overseeing the Division of Neurology within Pediatrics suggests he manages both clinical services and academic programs related to pediatric neurological care.